Your shopping cart is empty
Return to Keywords
Articles by Keyword fortracking
This is out Library. Please click on the article title to view the details.
submitted by: admin on 09/19/2013
The FDA does not have sufficient funds to police Big Pharma adequately. In fact, a significant amount of FDA funding comes from the drug industry in the form of fast tracked drug programs. Congress is the culprit.
submitted by: admin on 06/24/2017
Here at DoctorSaputo.com we hold the philosophy that each of us has the potential to improve and maintain our mind/body health at an optimal level. This is what we refer to as "self empowerment." We believe it is time for what Len Saputo, M.D. calls in his medical practice "patient centered care" ...and what we refer to here online...
submitted by: admin on 09/21/2013
Can we trust the FDA to protect us from Big Pharma and from the supplement industry? Fast tracking drugs has plusses and minuses. Should patients have the choice of trying drugs that are not yet on the market? Can we trust the drugs that are on the market that don't do that much? How much do conflicts of interest come into play?
submitted by: admin on 06/24/2017
New drugs are the poorest tested and Americans are the guinea pigs for the first few years after release. Most new drugs have new side effects reported and 20% wind up off the market or with black box warnings.
submitted by: admin on 10/12/2013
Despite Obama's promise to clean up our air, he has backtracked on legislation supporting lowering the levels of smog in our air. He has bowed to power plants and factories such as Dow Chemical by stating that it would cost thousands of jobs and $90 billion dollars in the bottom line for these polluting corporations. The cost is our health. There will be...
submitted by: admin on 10/17/2013
Americans last year got access to 24 new medications before they became available in Europe. User fees from drug companies made this possible; they now provide about 1/3 of all funding that the FDA gets. This sets up a serious conflict of interest for the FDA that makes them beholden to Big Pharma's wishes. Far too many look alike drugs are...
submitted by: admin on 02/09/2014
According to a Yale School of Medicine study published in the January 22, 2014 issue of JAMA, reviewed 188 drugs and technologies from 2005-2012 and documented that more than 1/3 of the drugs were approved not only on the basis of a single clinical trial, but also were often small, short, and involved surrogate metrics rather than clear clinical endpoints. It...
submitted by: admin on 05/26/2016
Lifestyle is our most important prescription for good health. On doctorsaputo.com you can track your progress over time using our unique tracking system on your very own home page. Once you become a member you can follow your lifesytyle changes and your improvement over time of any health care condition you have and see how much healthier you are.
submitted by: admin on 01/09/2014
A special editorial written by Donald Wright from Harvard University and published in the Journal of Law, Medicine, and Ethics pointed out that 90% of all new drugs approved by the FDA over the past 30 years are little or no more effective than drugs that are already on the market! They also commented that the safety of new FDA approved drugs is low....